Description
While the study demonstrates successful BBB opening via MRI contrast enhancement, it doesn’t measure whether this translates to increased temozolomide concentrations in tumor tissue. This pharmacokinetic gap is critical for understanding the mechanism of any therapeutic benefit.
Gap type: unexplained_observation Source paper: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial. (2025, The Lancet. Oncology, PMID:41308679)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:50.311974+00:00”, “resolution_summary”: “Resolved by hypothesis h-84808267: Synthetic Biology BBB Endothelial Cell Reprogramming. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-171918-9936a995.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-84808267”, “title”: “Synthetic Biology BBB Endothelial Cell Reprogramming”, “score”: 0.22, “reason”: “23 token overlaps; entity overlap: bbb”, “analysis_id”: “sda-2026-04-01-gap-008”, “target_gene”: “TFR1, LRP1, CAV1, ABCB1”, “target_pathway”: “LRP1 receptor-mediated transcytosis”, “disease”: “neurodegeneration”, “composite_score”: 0.726817, “confidence_score”: 0.6, “status”: “debated”, “pubmed_evidence_ids”: [“21374818”, “38182581”, “38993123”, “40161792”, “41676611”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-171918-9936a995”, “title”: “The study demonstrates that high-neural glioblastoma cells form synapses with neurons both in vitro and in vivo, but the underlying molecular mechanisms are not explained. Understanding these mechanisms could reveal novel therapeutic targets to disrupt this tumor-promoting interaction.\n\nGap type: unexplained_observation\nSource paper: A prognostic neural epigenetic signature in high-grade glioma. (None, None, PMID:38760585)”, “score”: 0.401, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-171918-9936a995”, “quality_score”: 0.62, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-173045-28238f1f”, “title”: “The study identifies KCNJ2 as a therapeutic target through CRISPR screening but doesn’t explain the mechanistic pathway by which this mechanosensory channel inhibition reduces neuronal death and proteinopathy. Understanding this mechanism is critical for rational drug development and predicting off-target effects.\n\nGap type: unexplained_observation\nSource paper: KCNJ2 inhibition mitigates mechanical injury in a human brain organoid model of traumatic brain injury. (2024, Cell stem cell, PMID:385”, “score”: 0.396, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-173045-28238f1f”, “quality_score”: 0.71, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.393, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193006-09757220”, “title”: “The abstract reports that pericyte senescence contributes to glioma growth and invasion, but the specific molecular mechanisms linking senescent pericytes to tumor progression are not explained. This gap is critical for understanding how radiation therapy may paradoxically promote tumor aggressiveness.\n\nGap type: unexplained_observation\nSource paper: Defective autophagy of pericytes enhances radiation-induced senescence promoting radiation brain injury. (2024, Neuro-oncology, PMID:39110121)”, “score”: 0.392, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193006-09757220”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a_task_9aae8fc5”, “title”: “AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-43 mechanistically contributes to this severity is unknown. Understanding this could identify TDP-43 as a therapeutic target for cognitive preservation in AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.391, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}